Chien‐Shing Chen

The Phosphoinositide-Dependent Kinase-1 Inhibitor 2-Amino-N-[4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]-acetamide (OSU-03012) Prevents Y-Box Binding Protein-1 from Inducing Epidermal Growth Factor Receptor

Karen To, Yi Zhao, Helen Jiang et al. · Molecular Pharmacology · 2007 · 33 citations

A modified regimen of pegylated liposomal doxorubicin, bortezomib and dexamethasone (DVD) is effective and well tolerated for previously untreated multiple myeloma patients

James R. Berenson, Ori Yellin, Chien‐Shing Chen et al. · British Journal of Haematology · 2011 · 31 citations

Phase <scp>II</scp> study of bortezomib in combination with rituximab, cyclophosphamide and prednisone with or without doxorubicin followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma

Michael Craig, Wahid T. Hanna, Fernando Cabanillas et al. · British Journal of Haematology · 2014 · 15 citations · Full text